You probably don’t think twice about putting on your socks – until your back makes it the hardest part of getting dressed. When ordinary movements become painful, even a little relief can matter. A new clinical trial suggests some of that relief could come from a surprisingly old-fashioned source: a soft belt wrapped around the lower back.
New recommendations based on extensive public engagement set out how the NHS could give patients faster access to AI advances with proportionate safeguards to protect patient safety and maintain high levels of trust. The National Commission into the Regulation of AI in Healthcare has today, 10 September 2026, published its recommendations on how the UK
New research paves way for novel therapies to reverse heart failure. Pioneering research by experts at the University of Sydney, the Baird Institute and the Royal Prince Alfred Hospital in Sydney has shown that heart muscle cells regrow after a heart attack, opening up the possibility of new regenerative treatments for cardiovascular disease. Following the
Analysis of data from 134 countries and territories shows wide differences between officially reported COVID-19 mortality rates and estimates based primarily on excess mortality. Official COVID-19 death figures in many countries differed significantly from estimates based primarily on excess mortality. Ariel Karlinsky of Hebrew University and Professor Moses Shayo of Hebrew University and King’s College London
A review led by University of Miami researchers examines how delivering stem cells directly into brain-supplying arteries could support recovery after ischemic stroke and identifies the evidence still needed before the approach becomes part of standard care. Key Takeaways Researchers from the University of Miami Miller School of Medicine and collaborating institutions have published a
Novartis announced positive topline results from its Phase III REMODEL-1/-2 trials of remibrutinib in relapsing multiple sclerosis.1 Remibrutinib, a highly selective and potent oral Bruton’s tyrosine kinase (BTK) inhibitor, demonstrated superiority versus teriflunomide in reducing annualized relapse rate (ARR) and inflammatory brain lesions with a favorable safety profile. The results of the REMODEL trials establish remibrutinib
First and only combination regimen to demonstrate statistically significant and clinically meaningful improvements in RFS and DMFS compared to KEYTRUDA alone for these patients in the adjuvant melanoma setting The Companies plan to present data at an upcoming international medical meeting and will engage with regulators on filing submissions for intismeran autogene in combination with
Ultra thin, flexible interface locates alternative signal pathways to bypass affected area Researchers from Houston Methodist and the University of Cambridge have developed a flexible device that wraps around the spinal cord and can simultaneously interpret multiple signals related to movement, sensation and internal body functions. The research demonstrates that a single device may be
CHIP trial extends shelf life compared with conventional room-temperature storage Key Takeaways Extending the shelf life of platelets with refrigeration didn’t hurt their hemostatic function for people undergoing complex cardiac surgery, the landmark CHIPS trial found. Platelets stored at 1-6°C (33.8-42.8°F) for up to 21 days were noninferior to platelets stored up to 7 days
The Lancet Diabetes & Endocrinology recently published a consensus piece on using GLP-1 medications for obesity in Europe. The paper, “Nutritional, Functional, and Psychological Considerations for Incretin-Based Therapies in Adults—an EASO, EFAD, and ECPO Consensus Statement“, aimed to provide guidance on best practices for clinicians prescribing obesity medications — but one could argue, it’s more likely to lead
